Top Markets
Coin of the day
ViewRay, Inc. ViewRay, Inc.

ViewRay, Inc.

VRAY
Rang in aandelen #37058
ViewRay, Inc. specializes in the development, production, and global... ViewRay, Inc. specializes in the development, production, and global distribution of advanced radiation therapy systems that leverage magnetic resonance imaging (MRI). These integrated systems are utilized to both image and deliver treatment for cancer patients in various countries, including the United States, France, Taiwan, and the United Kingdom. The company's key product, MRIdian, is an MRI-guided radiation therapy solution engineered to address critical concerns during treatment, such as beam distortion and potential skin toxicity. ViewRay's client base spans a diverse range of medical facilities, including university research and teaching hospitals, local community hospitals, private medical practices, government institutions, and independent cancer treatment centers. MRIdian systems are sold to these clients via ViewRay's direct sales force and through its established distribution channels. The company was founded in 2004 and operates out of its main office in Oakwood, Ohio.
Aandeelprijs
$0.014
Laatst gesynchroniseerd: 2023-08-21
Marktkapitalisatie
$2.07M
Verandering (1 dag)
-1.41%
Verandering (1 jaar)
0.00%
Land
US
Handel ViewRay, Inc. (VRAY)

Categorie

P/B-ratio voor ViewRay, Inc. (VRAY)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van ViewRay, Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor ViewRay, Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US